Thomas Vercruysse

7PUBLICATIONS
57CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsSpeciation and extinctionNanotoxicology, health and safetyNeurology and neuromuscular diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 03, 2024
Multiplexed multicolor antiviral assay amenable for high-throughput research.

Li-Hsin Li, Winston Chiu, Yun-An Huang

|Nov 05, 2022
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters.

Sapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe

|Jun 24, 2022
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.

Bas Calcoen, Nico Callewaert, Aline Vandenbulcke

|May 28, 2022
Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress Granules.

Joni Vanneste, Thomas Vercruysse, Steven Boeynaems

|Feb 15, 2022
The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2.

Christine Helsen, Tien Nguyen, Thomas Vercruysse

|Nov 18, 2021
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Ji Ma, Robbert Boudewijns, Lorena Sanchez-Felipe

Pageof 2

Frequent Collaborators

5 joint publications

Hendrik Jan Thibaut

5 joint publications

Kai Dallmeier

4 joint publications

Johan Neyts

3 joint publications

Lorena Sanchez-Felipe